The problem with doing this kind of trial on the face is that the face changes. Having a permanent filler on only one side is gonna look pretty weird after, say, five years.
ARTE is so desperate for business that this trial might be a ploy to force the enrollees to have ArteFill implanted on the other side in due course :-)
Am I the only one who immediately thought that this approach was potentially applicable to cellulite treatments as well, and what terminology would likely be used in characterizing the methodology?<
>> Beverly Hills Plastic Surgeon Launches Study to Evaluate ArteFill for Non-Surgical Nose Jobs
Tuesday November 6, 7:30 am ET
BEVERLY HILLS, Calif.--(BUSINESS WIRE)--Leading Beverly Hills, CA – based facial plastic surgeon, Dr. John Joseph announced today he is conducting a study with the use of ArteFill to reshape nasal contour deformities without the need for conventional surgery.
John H. Joseph, MD, Assistant Clinical Professor, Department of Head and Neck Surgery, University of California, Los Angeles, is conducting this study to evaluate ArteFill for the cosmetic improvement of nasal contour deformities which are naturally occurring, or a result of a past rhinoplasty surgery or trauma.
Dr. Joseph expects to enroll 20 patients by the end of March 2008. A patient satisfaction survey along with patient photos of the results and clinical grading are part of the current study protocol. These patients will be followed for one year after ArteFill treatment. After study completion, these findings will be submitted and are expected to be published in a peer reviewed plastic surgery journal.
According to the American Society for Aesthetic Plastic Surgery (ASAPS) there were approximately 300,000 rhinoplasties performed in 2006. Published studies indicate that approximately 10 percent of rhinoplasties need to be re-done or fine-tuned.
“Since ArteFill is a long-lasting tissue bulking filler, I have had success sculpting the nose and it seems clear that only a non-resorbable filler like ArteFill, can provide the long-lasting repair and treatment that my patients are seeking. It is a good alternative for those not wanting a second invasive surgery or even as an alternative to an initial surgery. I have already incorporated ArteFill in my medical practice for smile lines and I can now document the use of ArteFill for rhinoplasty revisions and other uses,” said Dr. Joseph.
Dr. Joseph received a research grant from Artes Medical, Inc. (NASDAQ: ARTE ) to conduct this study. For more information on Dr. Joseph at Brighton Medical Corporation or his study call (310) 859-7193 or visit www.drjohnjoseph.com . <<
News 
Market Data 
Discover 
AI
